Please use this identifier to cite or link to this item: https://doi.org/10.1007/s13758-011-0005-7
Title: Nano-sized albumin-copolymer micelles for efficient doxorubicin delivery
Authors: Wu, Y.
Shih, E.K.
Ramanathan, A.
Vasudevan, S. 
Weil, T. 
Issue Date: Dec-2012
Citation: Wu, Y., Shih, E.K., Ramanathan, A., Vasudevan, S., Weil, T. (2012-12). Nano-sized albumin-copolymer micelles for efficient doxorubicin delivery. Biointerphases 7 (1-4) : -. ScholarBank@NUS Repository. https://doi.org/10.1007/s13758-011-0005-7
Abstract: We present the discovery of a nano-sized protein- derived micellar drug delivery system based on the polycationic albumin precursor protein cBSA-147. The anticancer drug doxorubicin (DOX) was efficiently encapsulated into nanosized micelles based on hydrophobic interactions with the polypeptide scaffold. These micelles revealed attractive stabilities in various physiological buffers and a wide pH range as well as very efficient uptake into A549 cells after 1 h incubation time only. In vitro cytotoxicity was five-times increased compared to free DOX also indicating efficient intracellular drug release. In addition, multiple functional groups are available for further chemical modifications. Based on the hydrophobic loading mechanism, various classical anti-cancer drugs, in principle, could be delivered even synergistically in a single micelle. Considering these aspects, this denatured albumin-based drug delivery system represents a highly attractive platform for nanomedicine approaches towards cancer therapy. © The Author(s) 2012.
Source Title: Biointerphases
URI: http://scholarbank.nus.edu.sg/handle/10635/76620
ISSN: 19348630
DOI: 10.1007/s13758-011-0005-7
Appears in Collections:Staff Publications

Show full item record
Files in This Item:
There are no files associated with this item.

SCOPUSTM   
Citations

13
checked on Jul 11, 2018

WEB OF SCIENCETM
Citations

16
checked on Jun 25, 2018

Page view(s)

75
checked on May 4, 2018

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.